GREYX
Price
$10.54
Change
-$0.01 (-0.09%)
Updated
Jul 30 closing price
Net Assets
358.15M
MGLCX
Price
$18.36
Change
-$0.06 (-0.33%)
Updated
Jul 30 closing price
Net Assets
2.24B
Interact to see
Advertisement

GREYX vs MGLCX

GREYX vs MGLCX Comparison Chart in %
View a ticker or compare two or three
VS
GREYX vs. MGLCX commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GREYX is a Buy and MGLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.25B vs. GREYX (358M). GREYX pays higher dividends than MGLCX: GREYX (3.40) vs MGLCX (1.88). GREYX was incepted earlier than MGLCX: GREYX (11 years) vs MGLCX (12 years). MGLCX (1.94) is less costly to investors than GREYX (0.88). GREYX is a more actively managed with annual turnover of: 139.00 vs. MGLCX (35.00). MGLCX has a lower initial minimum investment than GREYX: MGLCX (1000) vs GREYX (1000000). GREYX annual gain was more profitable for investors over the last year : 18.44 vs. MGLCX (15.28). GREYX return over 5 years is better than : 8.01 vs. MGLCX (-9.46).
GREYXMGLCXGREYX / MGLCX
Total Expense Ratio0.881.9346%
Annual Report Gross Expense Ratio0.881.9445%
Fund Existence11 years12 years-
Gain YTD14.65713.844106%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets358M2.25B16%
Annual Yield % from dividends3.401.88181%
Returns for 1 year18.4415.28121%
Returns for 3 years35.0917.79197%
Returns for 5 years8.01-9.46-85%
Returns for 10 years44.6016.89264%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRO24.821.50
+6.43%
Sutro Biopharma Inc.
STGW8.490.41
+5.07%
Stagwell
SMMT13.440.64
+5.00%
Summit Therapeutics
AACBU10.68N/A
N/A
Artius II Acquisition Inc
SKYA1.34-0.03
-2.19%
SkyAI Inc.